| 2026 | 2025 | 2024 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2010 | 2009 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 468,2 M € | +2.9% | 454,9 M € | -1.3% | 461,0 M € | +12.0% | 411,7 M € | +8.4% | 379,8 M € | +9.6% | 346,5 M € | +6.3% | 326,1 M € | +11.9% | 291,4 M € | +1.2% | 288,0 M € | +15.8% | 248,6 M € | +1.6% | 244,7 M € | -4.3% | 255,8 M € | +17.0% | 218,7 M € | +10.1% | 198,6 M € | |
| EBITDA | 73,1 M € | +24.7% | 58,6 M € | +23.2% | 47,5 M € | -2.8% | 48,9 M € | -6.0% | 52,1 M € | +19.1% | 43,7 M € | +16.1% | 37,6 M € | -5.6% | 39,9 M € | +61.7% | 24,7 M € | -3.1% | 25,5 M € | -6.9% | 27,3 M € | -22.4% | 35,2 M € | +42.8% | 24,7 M € | +56.8% | 15,7 M € | |
| Operating profit | 39,4 M € | +41.8% | 27,8 M € | +9.4% | 25,4 M € | -18.2% | 31,0 M € | -11.0% | 34,8 M € | +8.7% | 32,0 M € | +14.3% | 28,0 M € | +24.9% | 22,4 M € | +82.5% | 12,3 M € | +25.3% | 9,8 M € | -11.7% | 11,1 M € | -47.0% | 21,0 M € | +66.7% | 12,6 M € | +1435.0% | 819,7 k € | |
| Profit/loss | 32,0 M € | +49.8% | 21,4 M € | +26.3% | 16,9 M € | -29.4% | 24,0 M € | -2.3% | 24,5 M € | +5.7% | 23,2 M € | +35.0% | 17,2 M € | +13.7% | 15,1 M € | +32.8% | 11,4 M € | +305.0% | -5,6 M € | -165.7% | 8,5 M € | -40.6% | 14,3 M € | +43.9% | 9,9 M € | +2402.5% | 396,3 k € | |
| Equity | 323,9 M € | +11.0% | 291,9 M € | +7.9% | 270,6 M € | +22.3% | 221,3 M € | +12.2% | 197,1 M € | +22.4% | 161,0 M € | +12.5% | 143,1 M € | +7.1% | 133,6 M € | +9.0% | 122,5 M € | +10.2% | 111,2 M € | -8.0% | 120,8 M € | +4.2% | 116,0 M € | +19.9% | 96,8 M € | +11.1% | 87,1 M € | |
| Total assets | 476,3 M € | +15.1% | 413,8 M € | +1.4% | 408,0 M € | +0.0% | 408,0 M € | -1.1% | 412,7 M € | +17.3% | 351,7 M € | +10.2% | 319,0 M € | +11.1% | 287,2 M € | +16.2% | 247,1 M € | -1.7% | 251,4 M € | +10.4% | 227,7 M € | -6.7% | 243,9 M € | +32.8% | 183,6 M € | +9.9% | 167,2 M € | |
| Cash | 647,9 k € | -81.3% | 3,5 M € | -36.5% | 5,5 M € | +264.5% | 1,5 M € | -84.5% | 9,7 M € | +6.4% | 9,1 M € | -42.7% | 15,9 M € | +8.1% | 14,7 M € | -29.2% | 20,7 M € | +76.3% | 11,8 M € | +12.6% | 10,4 M € | -41.6% | 17,9 M € | +132.3% | 7,7 M € | +1751.6% | 415,7 k € | |
| Debts | 136,0 M € | +23.0% | 110,6 M € | -11.8% | 125,4 M € | -27.5% | 173,1 M € | -15.1% | 203,9 M € | +22.8% | 166,0 M € | +10.0% | 151,0 M € | +17.8% | 128,1 M € | +29.6% | 98,9 M € | -12.7% | 113,2 M € | +39.6% | 81,1 M € | -19.1% | 100,3 M € | +62.4% | 61,7 M € | -5.5% | 65,3 M € | |
| Staff | 863,4 | 815,8 | 814,2 | 846,4 | 837,4 | 748,6 | 703,9 | 688,2 | 619,7 | 666 | 667,4 | 703,6 | 667,7 | 668,3 | ||||||||||||||
Public limited company · Wetteren · incorporated on 19/04/1946 · 863,4 ETP
Public limited company profitable and well capitalised. Cash position declining (-81.3%).
Solid counterparty for a standard engagement.
AJINOMOTO OMNICHEM is a Public limited company incorporated in 1946. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Wetteren. It employs on average 863,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette